Evidence map›Paper›PMID 34122980›Full record

ArticleChemical science2020

Differentiating Aβ40 and Aβ42 in amyloid plaques with a small molecule fluorescence probe.

Jing Yang, Biyue Zhu, Wei Yin, Zhihao Han, Chao Zheng, Peng Wang, Chongzhao Ran

Abstract read
In one paragraph

Article in Chemical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Preclinical evaluation of [EJNMMI research · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Peripheral proteinopathy in neurodegenerative diseases.Translational neurodegeneration · 2025
    Review
  9. Article
  10. Amyloid-β Effects on Peripheral Nerve: A New Model System.International journal of molecular sciences · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jing YangAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School Room 2301, Building 149, Charlestown Boston Massachusetts 021291 USA wangpeng@cpu.edu.cn cran@nmr.mgh.harvard.edu.
Biyue ZhuAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School Room 2301, Building 149, Charlestown Boston Massachusetts 021291 USA wangpeng@cpu.edu.cn cran@nmr.mgh.harvard.edu.
Wei YinAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School Room 2301, Building 149, Charlestown Boston Massachusetts 021291 USA wangpeng@cpu.edu.cn cran@nmr.mgh.harvard.edu.
Zhihao HanSchool of Engineering, China Pharmaceutical University Nanjing 210009 China.
Chao ZhengAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School Room 2301, Building 149, Charlestown Boston Massachusetts 021291 USA wangpeng@cpu.edu.cn cran@nmr.mgh.harvard.edu.
Peng WangAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School Room 2301, Building 149, Charlestown Boston Massachusetts 021291 USA wangpeng@cpu.edu.cn cran@nmr.mgh.harvard.edu.ORCID https://orcid.org/0000-0003-2359-908X
Chongzhao RanAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School Room 2301, Building 149, Charlestown Boston Massachusetts 021291 USA wangpeng@cpu.edu.cn cran@nmr.mgh.harvard.edu.ORCID https://orcid.org/0000-0002-3892-4108

Funding

Near infrared fluorescence imaging of reactive oxygen species in Alzheimer's diseaseR01AG055413 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI RAN, CHONGZHAO · 2018 to 2022
$2.1M
Near infrared Fluorescence Ocular Imaging of Soluble Amyloid Beta SpeciesR21AG059134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI RAN, CHONGZHAO · 2018 to 2019
$459k
Imaging active plaques of Alzheimers diseaseR21AG065826 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI RAN, CHONGZHAO · 2020 to 2020
$459k
NIA NIH HHS R01 AG055413NIA NIH HHS R21 AG059134NIA NIH HHS R21 AG065826
6 · The paper itself

Abstract

Differentiating amyloid beta (Aβ) subspecies Aβ40 and Aβ42 has long been considered an impossible mission with small-molecule probes. In this report, based on recently published structures of Aβ fibrils, we designed iminocoumarin-thiazole (ICT) fluorescence probes to differentiate Aβ40 and Aβ42, among which Aβ42 has much higher neurotoxicity. We demonstrated that

Identifiers

PMID34122980
PMCPMC8159352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.